Obsidian Therapeutics, Inc.

NasdaqCM:OBX Stock Report

Market Cap: US$0

Obsidian Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Madan Jagasia

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage42.54%
CEO tenureno data
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenureno data

Recent management updates

Recent updates

CEO

Madan Jagasia

no data
Tenure
US$1,315,770
Compensation

Dr. Madan Jagasia, M.D., M.S., is Member of Medical Advisory Board of Bone Marrow & Cancer Foundation. Dr. Madan Jagasia is Chief Executive Officer, President and Director of Obsidian Therapeutics, Inc. He...

Leadership Team

NamePositionTenureCompensationOwnership
Maria Fardis
Executive Chairman of the Boardno dataUS$110.91kno data
Madan Jagasia
Presidentno dataUS$1.32mno data
Dana Alexander
Chief Technical Officer2.3yrsUS$690.00kno data
Parameswaran Hari
Chief Medical Officer3.4yrsUS$723.95kno data
Julie Feder
Chief Financial Officerless than a yearno datano data
Jennifer Peterson
Chief People Officerno datano datano data
Peter Barrett
Secretary & Directorno datano datano data
2.3yrs
Average Tenure
58yo
Average Age

Experienced Management: OBX's management team is considered experienced (2.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/04 16:58
End of Day Share Price 2026/08/04 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Obsidian Therapeutics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.